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CD4+ T cell differentiation is regulated by specialized
antigen-presenting cells. Dendritic cells (DCs) pro-
duce cytokines that promote naive CD4+ T cell differ-
entiation into T helper 1 (Th1), Th17, and inducible
T regulatory (iTreg) cells. However, the initiation of
Th2 cell responses remains poorly understood,
although it is likely that more than one mechanism
might be involved. Here we have defined a specific
DC subset that is involved in Th2 cell differentiation
in vivo in response to a protease allergen, as well
as infection with Nippostrongylus brasiliensis. We
have demonstrated that this subset is controlled by
the transcription factor interferon regulatory factor
4 (IRF4), which is required for their differentiation
and Th2 cell-inducing function. IRF4 is known to con-
trol Th2 cell differentiation and Th2 cell-associated
suppressing function in Treg cells. Our finding
suggests that IRF4 also plays a role in DCs where it
controls the initiation of Th2 cell responses.
INTRODUCTION
Dendritic cells (DCs) play a key role in linking innate immune
recognition to the generation of adaptive immune responses
(Reis e Sousa, 2001). Upon innate immune recognition of
infection, DCs produce cytokines that promote naive CD4+
T cell differentiation into T helper 1 (Th1), Th17, and inducible
T regulatory (iTreg) cells (O’Shea and Paul, 2010; Zhou et al.,
2009). In contrast, it remains unclear which instructive signals
are necessary for Th2 cell differentiation and which cell types
are their relevant sources (Paul and Zhu, 2010; Pulendran and
Artis, 2012).
DCs are a heterogeneous population of professional antigen-
presenting cells (Hashimoto et al., 2011). Based on expression
of surface markers, they can be divided into distinct subpopu-
lations with different functions. In the skin-draining lymph
nodes, these include epidermal Langerhans cells (langerin+
CD11bloCD103) and dermal DCs, which can be divided into722 Immunity 39, 722–732, October 17, 2013 ª2013 Elsevier Inc.at least three subsets: CD103+ dermal DCs (langerin+CD11blo
CD103+), CD11bhi dermal DCs (langerinCD11bhiCD103), and
CD11blo dermal DC (langerinCD11bloCD103 DC) (Henri
et al., 2010). Epidermal Langerhans cells are critical for inducing
Th17 cell responses, whereas CD103+ dermal DCs are important
for Th1 cell responses (Haley et al., 2012; Igyarto et al., 2011;
King et al., 2010). Althoughmuch is known about the DC subsets
that control Th1 and Th17 cell-mediated immunity, the DCs
involved in the initiation of Th2 cell responses remain poorly
characterized.
IRF4, a member of the interferon-regulatory family of tran-
scription factors (Tamura et al., 2008), is expressed by Th2 cells
and is critical for their differentiation and function (Lohoff et al.,
2002; Rengarajan et al., 2002). Expression of this transcription
factor is also important for the ability of Foxp3+ regulatory
T cells to specifically inhibit Th2 cell-mediated responses (Zheng
et al., 2009). IRF4 was shown to regulate the development
of CD11bhiCD8a DCs in the spleen (Suzuki et al., 2004) and
the migration of DCs in the skin (Bajana et al., 2012). IRF4 also
controls plasma cell differentiation and class switch recom-
bination (Klein et al., 2006). In addition, IRF4 has been found to
control M2 polarization of macrophages (Satoh et al., 2010).
Finally, IRF4 inhibits TLR-induced inflammatory gene expression
in macrophages (Negishi et al., 2005).
Here we have identified a DC subset that appears to be
specialized for regulation of Th2 cell responses. These DCs
have unique phenotypic markers and their differentiation is
dependent on IRF4. Finally, elimination of this DC subset in
DC-specific Irf4/ mice results in ablation of allergen- and
infection-induced Th2 cell responses.
RESULTS
Bone-Marrow-Derived PDL2+ DCs Have a Distinct
Phenotype
In vitro generated bone-marrow-derived DCs (BMDCs) grown
with granulocyte macrophage colony-stimulating factor (GM-
CSF) (Inaba et al., 1992), typically exhibit an immature cell
surface phenotype characterized by low expression of the
costimulatory molecule CD86 (Figure 1A) and major histocom-
patibility complex MHC class II molecules (Figure 1B). However,
it has long been observed that these cultures also contain a
Figure 1. Bone-Marrow-Derived PDL2+ Dendritic Cells Are Phenotypically Mature and Hyporesponsive to Proinflammatory Stimuli
(A) Percentages of CD86hi BMDCs in GM-CSF-supplemented bone-marrow cultures from WT C57BL/6 andMyd88/Ticam1/mice. Gated on CD11c+ cells.
(B) Cell-surface expression of maturation markers (MHCII, CD40) and B7 family members (PDL1, PDL2) by CD86hi (shaded) and CD86lo (solid line) BMDCs.
(C) Induction of proinflammatory genes (IL-6, TNF-a, IL-1b, iNOS, and IL-12p35) in PDL2+ and PDL2 BMDCs stimulated with LPS or CpG DNA. PDL2+ and
PDL2 DC subsets were sorted from GM-CSF-supplemented bone-marrow cultures at day 5 and stimulated with LPS or CpG DNA for indicated times. Data are
representative of three independent experiments.
(D) Secretion of proinflammatory cytokines (IL-6, TNF-a) and nitric oxide by PDL2+ and PDL2 BMDCs stimulated with LPS or CpG DNA. Sorted PDL2+ and
PDL2 BMDCs were stimulated with LPS or CpG DNA for 24 hr. IL-6 and TNF-a amounts in the supernatant were measured by ELISA, and NO production
was measured by the Greiss assay as nitrite concentration. Data are representative of three independent experiments, and bar graphs show mean ± SD.
See also Figure S1.
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Control of Th2 Responses by IRF4-Dependent DCssmaller fraction of CD11c+CD86hiMHC-IIhi DCs (20%–35%),
which arise spontaneously in the absence of exogenous inflam-
matory mediators or microbial products (Jiang et al., 2007) (Fig-
ure 1A). In addition, the spontaneously mature DCs expressed
high amounts of CD40, programmed death ligand-1 (PDL1)
and PDL2 (Figure 1B). We found that PDL2 expression was
stably associated with this DC subset (see below), and we will
therefore refer to them here as PDL2+ DCs. Interleukin-4 (IL-4)
is known to induce PDL2 expression on dendritic cells (Ishiwata
et al., 2010). Interestingly, in vitro generation of PDL2+ DCs
could be promoted by IL-4 and inhibited by transforming growth
factor-b (TGF-b) (see Figure S1A available online). In addition, the
fraction of PDL2+ DCs in bone-marrow cultures could be
increased by mechanical disruption of E-cadherin-mediated
cell adhesion (Figure S1B), as previously described (Jiang
et al., 2007).
PDL2+ DCs Are Hyporesponsive to TLR Stimulation
The conventional immature BMDCs are highly sensitive to
stimulation with microbial TLR ligands: they undergo maturation
and cytokine production necessary for naive T cell activation(Reis e Sousa, 2001). As expected, stimulation of immature
PDL2 BMDCs with LPS or CpG DNA resulted in a robust
proinflammatory response, as measured by gene expression
and secretion of proinflammatory mediators. In contrast,
PDL2+ DCs are unresponsive to stimulation with LPS and CpG
DNA (Figures 1C and 1D). Unresponsiveness to LPS is likely
due to a low amount of TLR4 expression in PDL2+ DCs, whereas
unresponsiveness to CpG DNA might be due to reduced endo-
cytic activity of PDL2+ DCs (Figures S1C and S1D).
PDL2+ DCs Promote Th2 Responses
We next compared the ability of bone-marrow-derived PDL2+
DCs and conventional PDL2 DCs to stimulate T cell responses
in vitro. Because both DC subsets express similar amounts
of toll-like receptor-9 (TLR9), we used CpG DNA for their stim-
ulation. PDL2+ DCs, with or without CpG DNA treatment,
induced very robust proliferation of naive (CD62LhiCD44lo)
and effector or memory (CD62LloCD44hi) CD4+ T cells (Figures
2A and 2B) in the presence of anti-TCR and anti-CD3 stimu-
lation. However, they did not induce differentiation of naive
CD4+ T cells into Th1, Th2, or Th17 cell effectors (Figure 2A),Immunity 39, 722–732, October 17, 2013 ª2013 Elsevier Inc. 723
Figure 2. PDL2+ BMDCs Induce Th2 Responses in Effector or Memory CD4 T Cells
(A) Proliferation and cytokine production by naive CD4+ T cells (TN) cultured with PDL2
+ or PDL2BMDCs in the presence of soluble purified a-CD3 antibody and
CpG DNA, where indicated. Cytokines in the supernatant from cocultures at day 3 or 4 were measured by ELISA. Proliferation was measured by incorporation of
[3H]-thymidine during the last 16 hrs of coculture (cpm). *, not detected (same hereafter). Data are representative of at least three independent experiments, and
bar graphs show mean ± SD.
(B) Proliferation and cytokine production by effector or memory CD4+ T cells (Tem) stimulated with BMDCs, same as above (A). Data are representative of at least
three independent experiments, and bar graphs show mean ± SD.
(C) Dependence on TCR engagement for the effector or memory Th2 cell response induced by PDL2+ BMDCs. Tem cells were cocultured with PDL2+ or PDL2
BMDCs in the presence or absence of a-CD3ε. Data are represented as mean ± SD.
See also Figure S2.
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Control of Th2 Responses by IRF4-Dependent DCsnor did they induce expression of Foxp3 in naive CD4+ T cells
(data not shown). As expected, upon CpG DNA stimulation, the
conventional PDL2 DCs induced Th1 and Th17, but not Th2
cell differentiation of naive T cells (Figure 2A). To determine
the antigen specificity of the T cell response, we cultured
sorted DCs together with naive OT-II T cells in vitro in the pres-
ence of the cognate OVA peptide (amino acids 323–339).
Neither PDL2+ nor PDL2 DCs alone could induce Th2 cell dif-
ferentiation of OT-II T cells, whereas addition of exogenous IL-4
was sufficient to induce Th2 cell differentiation, as expected
(Figure S2A). Furthermore, unlike IL-4, addition of epithelial
cell-derived cytokines such as IL-25 and IL-33 did not induce
Th2 cell differentiation of naive T cells (Figure S2B), while
thymic stromal lymphopoietin (TSLP) had a modest effect (Fig-
ure S2C). Interestingly, although PDL2+ DCs failed to promote
naive T cell differentiation in vitro, they elicited a strong Th2
cell response in effector or memory CD4+ T cells (Figure 2B).
This response was T cell mediated, because it was dependent
on T cell receptor (TCR) engagement by anti-CD3ε antibody
(Figure 2C). The Th2 cell response by effector or memory
CD4+ T cells did not require PDL2 expression by DCs but
was partially dependent on PD1 and OX40 costimulatory mole-
cule expression in T cells (Figures S2D and S2E). Induction of724 Immunity 39, 722–732, October 17, 2013 ª2013 Elsevier Inc.Th2 cell-associated cytokines did not require MyD88 or TRIF
adaptor signaling pathways in DCs (Figure S2F).
PDL2+ DC Subset Exists In Vivo
Collectively, these data suggested that bone-marrow-derived
PDL2+ DCs might have specialized properties for the regulation
of Th2 cell responses. Therefore, we next looked for their in vivo
counterparts by using PDL2 expression as a marker. We found a
related DC population highly enriched in the mesenteric and
skin-draining lymph nodes (dLNs) (Figure 3A). Similar to their
bone-marrow-derived counterparts, PDL2+ DCs in the skin
dLNs expressed high amounts of CD80, CD86, CD40, and
PDL1 (Figure S3A). Moreover, similar to in vitro generated
PDL2+ DCs, in vivo PDL2+ DCs had reduced messenger RNA
(mRNA) expression of several TLRs (Figure S3B). In the skin
dLNs, different DC subsets can be identified based on expres-
sion of CD8a and CD205 (Dec205) (Henri et al., 2001). Langer-
hans cells (LCs) are CD205hiCD8aint and dermal DCs are
CD205intCD8alo. Gating on CD11c+PDL2+ DCs, we found
that this population contained a mixture of dermal DCs and
Langerhans cells, as determined by CD8a and CD205 staining
(Figure S3D). Moreover, by staining for epithelial cell adhesion
molecule (EpCAM), which is highly expressed by LCs (Borkowski
Figure 3. PDL2+ DCs Are Present in Skin-Draining Lymph Nodes and Regulate Effector or Memory Th2 Response
(A) Percentage of PDL2+ DCs in different lymphoid organs in vivo during homeostasis. BM, bone marrow; Mes LN, mesenteric lymph nodes; skin dLN, skin-
draining lymph nodes.
(B) Proliferation and cytokine production by total splenic CD4+ T cells stimulated for 3–4 days with PDL2+ or PDL2 skin dLN DCs, plus or minus LPS stimulation.
Data are representative of at least three independent experiments, and bar graphs show mean ± SD.
(C) IL-4–eGFP expression by total CD4+ T cells from 4get mice stimulated with skin dLN PDL2+ or PDL2 DCs. Data are representative of three independent
experiments.
(D) IL-4 and IFN-g secretion by Tn and Tem cells stimulated with skin dLN DCs. Data are representative of three independent experiments, and bar graphs show
mean ± SD.
(E) IL-4-eGFP expression by Tem cells from 4get mice stimulated with skin dLN DCs. Data are representative of two independent experiments.
See also Figure S3.
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were LCs (Figure S3E). Dermal DCs can be divided into at least
three subsets. The C-type lectin CD301b (Mgl2) has recently
been identified as a specific marker for CD207 (Langerin) nega-
tive, CD103 negative dermal DCs (Kumamoto et al., 2009). To
determine whether cutaneous PDL2+ DCs contained this subset
of dermal DCs, we stained these cells for CD301b and found
that PDL2+ DCs could be divided into CD301b and CD301b+
subsets (Figure S3F). Moreover, the PDL2+CD301b+ cells were
CD103 negative, as expected (Figure S3F). Furthermore, the
PDL2+ DCs from the skin dLNs expressed CCR7, consistent
with them being migratory DCs (Figure S3A). In addition,
PDL2+ DCs were able to take up and process a subcutaneously
injected fluorescently labeled antigen (DQ-OVA) (Figure S3C),indicating that they have normal endocytic activity in contrast
to bone-marrow-derived PDL2+ DCs.
Lymph Node PDL2+ DCs Promote Th2 Cell Response
Similar to their bone-marrow-derived counterparts, PDL2+ DCs
from skin dLNs induced proliferation of splenic CD4+ T cells,
but unlike PDL2 DCs, they failed to induce interferon-g
(IFN-g) or interleukin-17 (IL-17) production by T cells (Figure 3B).
They also did not induce Foxp3 expression by T cells (Fig-
ure S3G). However, PDL2+ DCs from skin dLN did induce IL-4
reporter expression in T cells from 4get mice, in which GFP
marks cells with IL-4 gene transcription (Mohrs et al., 2001)
(Figure 3C). In addition, similar to in vitro generated DCs, skin
dLN PDL2+ DCs induced a Th2 cell cytokine response fromImmunity 39, 722–732, October 17, 2013 ª2013 Elsevier Inc. 725
Figure 4. IRF4 Expression Is Critical for the Development of Bone-Marrow-Derived PDL2+ DCs
(A) Microarray analysis of log2 transformed expression amounts from three BMDC populations (PDL2+, PDL2, and LPS stimulated PDL2). Irf4 is indicated.
Genes displayed correspond to those identified as significant by RNA-Seq analysis.
(B) IRF4mRNA and protein expression in PDL2+ BMDCswas examined by real-time RT-PCR and flow cytometry, respectively. Data are representative of at least
three independent experiments.
(C) Percentages of PDL2+ BMDCs in WT, Irf4+/ and Irf4/ bone-marrow cultures. Data are representative of three independent experiments.
(legend continued on next page)
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Control of Th2 Responses by IRF4-Dependent DCseffector or memory CD4+ T cells, but did not induce Th2 cell
differentiation of naive T cells (Figures 3D and 3E). Collectively,
these results suggest that PDL2+ DCs from skin dLNs (specif-
ically, PDL2+CD301b+ DCs, see below) are in vivo counterparts
of bone-marrow-derived PDL2+ DCs and that this DC subset
might be specialized for controlling Th2 cell responses.
Differentiation of PDL2+ DCs Is Dependent on IRF4
To gain further insight into the unique features of PDL2+ DCs
and the mechanism for their Th2 cell regulatory ability, we com-
pared gene-expression profiles of PDL2+ and PDL2 BMDCs
by microarray analysis (Figure 4A). Among the genes differen-
tially expressed in these DC populations, the transcription factor
IRF4 was preferentially expressed in the PDL2+ DC subset,
as validated by mRNA and protein expression (Figure 4B). We
therefore investigated whether IRF4 was required for the differ-
entiation of PDL2+ DCs. We generated BMDCs from wild-type
(WT) and Irf4-deficient mice (Klein et al., 2006) and found that
in the absence of IRF4, the differentiation of PDL2+ DCs was
almost completely blocked (Figure 4C). Retroviral reconstitution
of IRF4 into IRF4-deficient progenitors restored the differentia-
tion of these cells, as indicated by the presence of PDL2 and
CD301b-positive DC subset (Figure S4A).
RNA-seq analysis confirmed that the expression profile of
Irf4/ BMDCs was similar to WT PDL2 BMDCs and different
from that of PDL2+ BMDCs, highlighting an essential role for
IRF4 in directing PDL2+ DC development in vitro (Figures 4D
and 4E). Principal component analysis (PCA) revealed that a sub-
set of genes that were significantly upregulated in PDL2+ BMDCs
and downregulated in the Irf4/ DC population accounted for
the principal biological sample variance not associated with
mean gene-expression amounts (Figure 4E). Gene-ontology
analysis underscored that, within this subset, genes associated
with lymphocyte activation and T cell development were specif-
ically upregulated in PDL2+ BMDCs, whereas those associated
with microbial defense responses were downregulated (Fig-
ure S4B). Together these results suggest that IRF4 plays a critical
role in PDL2+ DC differentiation in vitro.
IRF4 usually cooperates with transcription factors of the Ets
or AP-1 family in a cell-type-specific manner through binding
to composite DNA motifs to mediate different transcription
programs (Ciofani et al., 2012; Glasmacher et al., 2012; Li
et al., 2012; Tussiwand et al., 2012). We therefore examined
expression of Ets and AP-1 transcription factors in PDL2+
DCs and found that some members of the two families were
selectively expressed (Figures S4C and S4D). In particular,
the Ets family members SpiB, SpiC and Ehf, as well as the
AP-1 family member Batf3, were expressed at higher con-
centrations in PDL2+ DCs. These transcription factors may
thus cooperate with IRF4 to drive the PDL2+ DC-specific
gene-expression program, a possibility that will be investigated
in future studies.(D and E) RNA-seq analysis of gene expression in three BMDC populations (
RPKM values for genes with PC2 scores greater than a designated absolute thres
RPKM values (cloudy blue) plotted according to two PCs that account for > 8
describes differential expression between populations. Sample loading vectors
Hochberg adjusted p value < 1050 by negative binomial testing) are displayed.
See also Figure S4.Importantly, IRF4 was also specifically expressed in vivo in
PDL2+ DCs in the skin dLNs (Figure 5A). We next crossed
Irf4flox/floxmice (Klein et al., 2006) withCd11c-cremice, which de-
letes predominantly in DCs (Caton et al., 2007), to generate mice
with Irf4 deleted in DCs (hereafter referred to as Irf4flox/flox
xCd11c-cremice). We found that the PDL2+CD301b+ DC subset
was almost completely eliminated, whereas other DC subsets
such as CD103+ dermal DCs and Langerhans cells appeared un-
affected in the skin dLNs of Irf4flox/floxxCd11c-cre mice (Figures
5B and 5C). Nevertheless, a normal number of PDL2+CD301b+
DCs were still detected in the dermis of Irf4flox/floxxCd11c-cre
mice (Figure 5D). These data indicate that IRF4 is required for
the presence of CD301b+PDL2+ DCs in skin dLNs, but is not
essential for their development in the dermis in vivo.
IRF4 in DCs Drives Th2 Responses
Next, to investigate the role of IRF4-dependent CD301b+PDL2+
DCs in Th2 cell responses in vivo, Irf4flox/floxxCd11c-cre mice
were immunized with OVA by using either LPS or papain as
Th1 and Th2 cell inducing adjuvants, respectively. The amount
of cytokine production by skin dLN cells was assessed after
in vitro restimulation. While the Th1 cell response induced
by immunization with OVA plus lipopolysaccharide (LPS)
was unimpaired (Figure 6A), the OVA plus papain-induced
Th2 cell response, as measured by secretion of IL-4, IL-5, and
IL-13, was almost completely ablated in Irf4flox/floxxCd11c-cre
mice (Figure 6B). Consistent with this, Irf4flox/floxxCd11c-cre
mice had significantly lower percentages of IL-4-producing but
not IFN-g-producing CD4+ T cells after OVA plus papain
immunization, suggesting that IRF4 plays a role in DCs in
controlling the papain-induced Th2 cell response (Figure 6C).
Additionally, Irf4flox/floxxCd11c-cre mice produced significantly
lower amounts of immunoglobulin G1 (IgG1) and IgE after
immunization with OVA plus papain, suggesting a defect in the
Th2 cell-dependent antibody response as well (Figure 6D).
To further examine the role of IRF4 in DCs in controlling
Th2 cell responses, we used another commonly used Th2
cell-mediated immunity model—Nippostrongylus brasiliensis
infection. In the draining mesenteric lymph nodes 7 days after
infection, Irf4flox/floxxCd11c-cre mice had significantly lower
numbers of IL-4-, IL-5-, and IL-13-producing CD4+ T cells
(Figure 7). A reduced Th2 cell response was also seen in the
draining mediastinal LNs of Irf4flox/floxxCd11c-cre mice (data
not shown). Collectively, these data indicate that IRF4 ex-
pression in DCs is important for regulation of a variety of Th2
cell responses and further suggest that PDL2+ DCs play a
specialized role in Th2 cell responses.
DISCUSSION
In contrast to steady progress in characterization of the
mechanisms of Th1, Th17, T follicular helper, and Treg cellWT PDL2+, WT PDL2, and Irf4 /). Heatmap of square root transformed
hold value of ± 2.38 (D). Biplot derived from PCA analysis of gene summarized
0% of total sample variance (E). PC1 describes overall expression and PC2
and the symbols of overlapping, differentially expressed genes (Benjamini-
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Figure 5. IRF4 Expression Is Critical for the Presence of PDL2+CD301b+ DCs in Skin dLNs
(A) IRF4 protein expression in PDL2+ skin dLN DCs were examined by flow cytometry.
(B) MHCIIhiCD11c+ DCs from skin dLNs of WT and Irf4flox/floxxCd11c-cre mice were examined by flow cytometry for PDL2, CD301b, CD103, and EpCAM
expression. The percentages of PDL2+CD301b+ and PDL2+CD301b DCs (left), dermal CD103+ DCs (middle), and EpCAM+ Langerhans cells (right) were
shown as indicated. Data are representative of three independent experiments.
(C) Percentages of PDL2+CD301b+ DCs in the skin dLNs of WT and Irf4flox/floxxCd11c-cre mice. Data are represented as mean ± SD. **p < 0.01.
(D) Percentages of PDL2+CD301b+ DCs in the ear dermis of WT and Irf4flox/floxxCd11c-cre mice. Data are represented as mean ± SD.
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Figure 6. IRF4 Expression in DCs Is Essential for the Papain-Induced Th2 Cell Response
(A and B) LPS-induced Th1 cell response (A) and papain-induced Th2 cell response (B) in WT and Irf4flox/floxxCd11c-cre mice. WT and Irf4flox/floxxCd11c-cre
mice were immunized subcutaneously with OVA plus either LPS or papain as Th1 and Th2 cell-inducing adjuvants, respectively. CD4+ T cells were sorted from
inguinal and popliteal LNs at day 6 and stimulated with irradiated splenic APCs and titrating doses of OVA for 4 days. IFN-g (for LPS response) and IL-4, IL-5,
and IL-13 (for papain response) production was measured by ELISA. Data are representative of at least three independent experiments, and bar graphs show
mean ± SD.
(C) Percentages of IL-4- or IFN-g-producing CD4+ T cells in draining inguinal and popliteal LNs in WT and Irf4flox/floxxCd11c-cremice 6 days after subcutaneous
immunization with OVA plus papain. Data are represented as mean ± SD. ***p < 0.001.
(D) OVA-specific IgG1 and total IgE amounts in the serum were measured by ELISA in WT and Irf4flox/floxxCd11c-cre mice at day 21 after subcutaneous
immunization with OVA plus papain at day 0 and day 14. Data are represented as mean ± SD. ***p < 0.001, ****p < 0.0001.
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Control of Th2 Responses by IRF4-Dependent DCsdifferentiation, induction of Th2 cell responses remains poorly
understood. Although many models have been proposed, the
relevant signals and cell types involved in the initiation of Th2
cell responses are still unknown. Likewise, the innate sensor
mechanisms responsible for the initiation of Th2 cell responses
remain to be elucidated.Here we investigated functional properties of a DC population
characterized by expression of PDL2. These DCs were found
in GM-CSF bone-marrow cultures, as well as in mesenteric
and skin-draining lymph nodes. Uncharacteristically for DCs,
they were unresponsive to stimulation with TLR ligands. Both
bone-marrow-derived and dLN PDL2+ DCs strongly inducedImmunity 39, 722–732, October 17, 2013 ª2013 Elsevier Inc. 729
Figure 7. IRF4 Expression in DCs Is Essen-
tial for Th2 Cell Responses Induced after
Infection with Nippostrongylus Brasiliensis
Percentages of IL-4-, IL-5-, and IL-13-producing
CD4+ T cells in draining mesenteric LNs in
WT and Irf4flox/floxxCd11c-cre mice 7 days after
subcutaneous infection with Nippostrongylus
brasiliensis. Data are represented as mean ± SD.
**p < 0.01, ***p < 0.001.
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Control of Th2 Responses by IRF4-Dependent DCsnaive CD4 T cell proliferation, but not differentiation into any of
the known T helper lineages. Surprisingly, however, bone-
marrow-derived and skin dLN PDL2+ DCs induce robust acti-
vation of Th2 effector or memory cells. This finding suggests
that restimulation of effector or memory CD4+ T cells might be
controlled by distinct DC subsets, although the mechanism for
such specificity is currently unclear.
Gene-expression analyses revealed that PDL2+ BMDCs ex-
pressed high amounts of the transcription factor IRF4 compared
to PDL2 BMDCs. IRF4 has a T cell-intrinsic function in Th2 cell
differentiation (Lohoff et al., 2002); it functions in regulatory
T cells to control Th2 cell-mediated immune responses (Zheng
et al., 2009), it controls plasma cell differentiation and class
switch recombination (Klein et al., 2006), and finally it negatively
regulates TLR signaling (Negishi et al., 2005) and promotes M2
polarization of macrophages (Satoh et al., 2010). Together, these
prior studies point to an important contribution of IRF4-depen-
dent gene expression in Th2 cell-mediated immunity. In addition,
IRF4 has been previously implicated in the development of
CD11bhiCD8a conventional DCs in the spleen (Suzuki et al.,
2004) and in the regulation of cutaneous DC migration (Bajana
et al., 2012). More recently, it was shown that IRF4-dependent
CD103+CD11b+ DCs drive mucosal Th17 cell differentiation in
draining mesenteric lymph nodes (Persson et al., 2013; Schlitzer
et al., 2013).
We found that PDL2+CD301b+ DC differentiation in vitro and
in vivo was dependent on DC-specific expression of IRF4
and that Irf4flox/floxxCd11c-cre mice were deficient in Th2 cell
responses to a protease allergen and a parasitic nematode
N. brasiliensis. Consistent with this result, elimination of
CD301b+ DCs by an alternative strategy (based on the speci-
ficity of CD301b expression) also resulted in ablation of Th2
cell responses (see accompanying paper by Kumamoto et al.
2013). Although the previously reported IRF4-dependent
control of DC migration (Bajana et al., 2012) can contribute
to this phenotype, we find both a specific defect in the
Th2 cell response in Irf4flox/floxxCd11c-cre mice and an ex-
tensive IRF4-dependent gene-expression program in PDL2+
CD301b+ DCs.
Although the involvement of DCs in Th2 cell responses has
been previously reported (Bell et al., 2013; Hammad et al.,
2010; Leon et al., 2012; Phythian-Adams et al., 2010; Plantinga
et al., 2013; Steinfelder et al., 2009; Tang et al., 2010), it730 Immunity 39, 722–732, October 17, 2013 ª2013 Elsevier Inc.has been unknown whether there is a
specialized subset of DCs performing
this function. Although our findings
demonstrate the role of IRF4-dependentPDL2+CD301b+ DCs in Th2 cell responses to protease allergen
and parasitic infection, it is possible that Th2 cell responses to
other stimuli or in other anatomical locations might be mediated
by different DC subsets. Importantly, PDL2+CD301b+ DCs are
unable to induce Th2 cell differentiation of naive T cells in vitro,
suggesting that an additional cell type present in vivo but not
in the in vitro system might be required. In summary, our data
indicate that in addition to Th2 cells, Treg cells, and M2 macro-
phages, IRF4 plays an essential role in DCs in controlling Th2
cell responses.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, Tnfrsf4/, Irf4flox/flox, OT-II, and 4get mice were purchased from
Jackson laboratories. Cd11c-cre (Caton et al., 2007), Pdcd1/ (Nishimura
et al., 1999), Foxp3-GFP.KI (Fontenot et al., 2005), Pdcd1lg2/ (Nguyen
et al., 2002), and Irf4/ (Klein et al., 2006) mice have been described
previously. Animals were 6–8 weeks at time of analyses and were all on
a C57BL/6 background. Animals were bred and maintained in a conven-
tional, specific pathogen-free facility at Yale University, and all animal
experiments were performed in accordance with regulatory guidelines
and standards set by the Institutional Animal Care and Use Committee
of Yale University.
Reagents and Antibodies
OVA and LPS were purchased from Sigma Aldrich. Papain was purchased
from Calbiochem, EMD Millipore. CpG DNA and OVA peptide (aa 323–339)
were generated by the Keck facility. DQ-OVA was purchased from Mole-
cular Probes. Flow cytometry antibodies used include CD86, CD80,
CD83, CD11b, CD103, CCR7, CD40, MHCII I-Ab, CD276 (B7-H3), CD11c,
CD8a, CD205 (Dec-205), IFN-g, IL-4, IL-5, and IL-13, all from BD Biosci-
ences. CD326 (EpCAM), CD274 (PDL1) and CD273 (PDL2), and IRF4
antibodies were purchased from eBioscience. Recombinant IL-4, IL-25,
IL-33, TSLP, and TGF-b were purchased from R&D Systems. CD301b anti-
body was a generous gift from Drs. Yosuke Kumamoto and Akiko Iwasaki.
Retroviral constructs encoding IRF4 was kindly provided by Dr. Alessandra
Pernis.
Bone-Marrow DC Cultures
BMDCs were generated from bone-marrow cultures of 1.0 3 106 cells per
ml cultured for 5 days in granulocyte-macrophage colony-stimulating factor.
BMDC populations were purified by flow cytometry and stimulated with LPS
(100 ng/ml), CpG-DNA (3 mM), IL-4 (100 ng/ml), or TGF-b (10 ng/ml).
For endocytosis assays, bone-marrow-derived DCs were incubated on day
5 for 20 min at 4C or 37C with OVA-FITC (100 mg/ml), DQ-OVA (100 mg/ml),
Dex-FITC (500 mg/ml), and CpG-FITC (3 mM). Cells were collected and
thoroughly washed followed by examination by flow cytometry.
Immunity
Control of Th2 Responses by IRF4-Dependent DCsIn Vivo DC Isolation
dLNs were homogenized with single frosted slides and filtered to obtain
a single-cell suspension. Dermal and epidermal sheets were obtained after
treatment of the ear skin with Dispase II (2mg/ml) in PBS for 1 hr at 37C.
Dermal sheets were digested in RPMI 1640 medium with 10% FCS, collage-
nase type D (6 mg/ml), and hyaluronidase (2 mg/ml) at 37C for 1hr with
frequent pipetting to obtain a single-cell suspension.
Immunizations
Mice were immunized subcutaneously in the rear footpads with either 50 mg
papain and 50 mg OVA in PBS or 5 mg LPS and 50 mg OVA emulsified in
incomplete Freund’s adjuvant (IFA). Popliteal and inguinal lymph nodes were
isolated from mice 6 days later, and CD4+ T cells were purified by magnetic-
activated cell sorting. Purified CD4+ T cells (13 105) were cultured in U-bottom
96-well tissue culture plates with irradiated splenocytes as antigen-presenting
cells (3 3 105) and titrating doses of antigen for approximately 96–120 hr.
Supernatants were collected to assess cytokine production by ELISA. For
intracellular cytokine staining, popliteal and inguinal lymph nodes were iso-
lated and homogenized from mice at day 6 after immunization. Cells were
stimulated in U-bottom 96-well tissue culture plates with 20 ng/ml PMA and
1 mg/ml ionomycin (Sigma) for 2 hrs at 37C and another 4 hrs at 37C in
the presence of Golgi Plug (BD Biosciences). Cells were then fixed and
permeabilized with BD Cytofix/Cytoperm Kit (BD Biosciences) and stained
with anti-cytokine antibodies for 1 hr on ice.
Nippostrongylus Brasiliensis Infection
We subcutaneously injected 625 third-stage larvae of N. brasiliensis, purified
as described, into mice (Voehringer et al., 2006). Mice were sacrificed at day
7 after infection, and mediastinal and mesenteric lymph nodes were collected.
Cells were restimulated in vitro and subjected to intracellular cytokine staining
as previously described.
DC and T Cell In Vitro Coculture
Flow cytometry-sorted DCs (23 104) were cocultured with either 13 105 naive
CD4+ T cells (CD44loCD62Lhi) or 1 3 105 effector or memory CD4+ T cells
(CD44hiCD62Llo) purified by flow cytometry in the presence of soluble anti-
CD3ε (1 mg/ml) for 72–96 hr. IL-4, IL-25, IL-33, or TSLP (10 ng/ml) was added
at the beginning of the culture where indicated. T cell proliferation was
assessed by adding [3H]-thymidine for the last 12–16 hrs of the culture.
Supernatants were collected to determine cytokine production by ELISA.
Enzyme Linked Immunosorbent Assay (ELISA)
Paired antibodies against IL-4, IL-5, IL-13, IL-6, tumor necrosis factor-a (TNF-
a), IFN-g, and IL-17 were purchased from BD Biosciences to perform ELISAs.
Gene-Expression Analysis
Total RNA from the different DC subsets was isolated with the RNeasy kit
(QIAGEN) and prepared for microarray and RNA-seq at the Yale Center for
Genome Analysis (YCGA). RNA samples for microarray study were applied
to aGeneChipMouseGenome 430 Array. ScannedCEL files were background
corrected, normalized, and summarized by using the oligo (2.12, Biocon-
ductor) package. RNA samples for RNA-seq analysis were sequenced on an
Ilumina Hi-Seq 2000. Reads were mapped to the mm9 genome reference
sequence with the bowtie (0.12.7) algorithm. Read sequences were aligned
to the mm9 reference genome and calculated with the easyRNaseq (2.12,
Bioconductor) package. Gene ontology for RNA-seq data was performed
with the goseq (2.12, Bioconductor) package.
Statistics
Data were analyzed with Student’s t test with Prism4 (GraphPad Software;
GraphPad, SanDiego, CA). Data are represented asmean± SD.Normalization,
parametric statistical testing, RPKM calculation, and PCA analysis of whole-
genome-expressiondatawasperformedwith theRstatistical language (2.15.3).
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